Notably, sartans, the top hits in C9-ALS SMs, were also effective in microglia spheroids, suggesting their ability to reduce IL-6 and IL-8 in both platforms (Figure 2G). The gene discussed is CXCL8; the disease is amyotrophic lateral sclerosis.